/ Print /

Health Management

Seven barriers to prescribing PCSK9 inhibitorsThe National Lipid Association releases interesting survey results on PCSK9 inhibitors prescription approval process.
Pharmaceutical pipeline: Top 4 conditions to watch
Pharmaceutical pipeline: Top 4 conditions to watchAlthough drug spend is increasing for inflammatory conditions, diabetes, and oncology, there are some promising developments in the pipeline.
Four health systems develop opioid mitigation programsAlternatives to opioids programs emerge as viable tools to mitigate the crisis.
Patient follow-up: Here’s what you’re doing wrongAHIP 2017: SummaCare exec shares their best practices for patient care outreach.
Retail clinic pros and cons: Impact on healthcare spending
Retail clinic pros and cons: Impact on healthcare spendingA new RAND analysis of retail clinics finds they could be increasing healthcare costs.
Why you need to pay attention to precision medicineDigital health pioneer Eric Topol talks about plans for a four-year precision medicine study at AHIP 2017.
Ovarian cancer: Possible advantage of high blood pressureNew research shows hypertension, diabetes influence survival of ovarian cancer patients in different ways.
Surprising link found in black women breast cancer riskAlcohol consumption is known to be a risk factor for breast cancer based on studies predominantly done in white women. Now, a University of North Carolina Lineberger Comprehensive Cancer Center study has found the same risk exists for black women.
Multiple myeloma treatment advances: What health execs should knowIt has been an exciting time at the Myeloma Institute at the University of Arkansas for Medical Sciences, on all fronts, namely, embarking on research that could play an important role in the development of preventative and curative strategies for multiple myeloma in the future.
Three ways to build a better population health teamHere are three things to consider when developing a population health management team at your organization.